Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study - Scorecard - MDSpire

Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study

  • By

  • Marta Nowak

  • Anna Maria Cybulska

  • Aleksandra Derezińska

  • Elżbieta Grochans

  • Mariusz Panczyk

  • Katarzyna Kęcka

  • Kamila Rachubińska

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Assessing Quality of Life in Individuals with Neovascular Age-Related Macular Degeneration Pre- and Post-Intravitreal Treatment: A Longitudinal Observational Analysis

At a Glance

CategoryDetail
ConditionNeovascular Age-Related Macular Degeneration
Key MechanismsIntravitreal injections of anti-VEGF agents reduce intraocular VEGF levels, stabilizing or improving vision.
Target PopulationIndividuals aged 50 and older with neovascular age-related macular degeneration.
Care SettingOphthalmology clinics providing intravitreal therapy.

Key Highlights

  • Significant improvement in vision-related quality of life post-treatment.
  • Association between quality of life and visual function parameters.
  • Patients reported low quality of life at baseline.
  • Better visual acuity and contrast sensitivity linked to higher quality of life scores.
  • Psychosocial benefits observed with intravitreal therapy.

Guideline-Based Recommendations

Diagnosis

  • Utilize standardized questionnaires to assess vision-related quality of life.

Management

  • Administer intravitreal anti-VEGF therapy as the standard treatment for neovascular AMD.

Monitoring & Follow-up

  • Regularly evaluate visual acuity and quality of life metrics post-treatment.

Risks

  • Consider potential visual disturbances and their impact on quality of life.

Patient & Prescribing Data

121 patients aged 51 to 90 years with neovascular AMD.

A course of seven intravitreal injections showed statistically significant improvements in quality of life.

Clinical Best Practices

  • Adopt a holistic approach to patient care, addressing both clinical and psychosocial aspects.
  • Encourage adherence to treatment by highlighting potential quality of life improvements.

Related Resources & Content

Original Source(s)

Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study

  • by Marta Nowak, Anna Maria Cybulska, Aleksandra Derezińska, Elżbieta Grochans, Mariusz Panczyk, Katarzyna Kęcka, Kamila Rachubińska

  • May 29, 2026

Related Content

Successful treatment of refractory focal eosinophilic myositis with extra-ocular muscle involvement using tocilizumab: a case report

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min
Primary orbital solitary fibrous tumor with an 18-year course of five recurrences and extensive sinonasal metastasis following eyeball enucleation: a case report